Introduction
Considering the limited availability of non-renewable resources like coal and fossil fuels, it is necessary to find a potential alternative resource from biomass that can replace fossil fuel-based chemicals. To replace polyethylene-based plastics, several biobased polymers have been studied intensively. One such, polyamide 4, also known as nylon-4, is a biobased biodegradable polymer composed of repeated units of gamma-aminobutyric acid (GABA). GABA is a non-protein amino acid and is an important inhibitor of neurotransmission in the brain [1, 2] . GABA is actively studied for its potential use as a precursor of 2-pyrrolidone, which is used as a monomer to synthesize nylon 4 [3] .
In Escherichia coli and many other organisms, GABA is a native metabolic intermediate. GABA is produced from the GABA pathway, in which glutamate decarboxylase (GadB) catalyzes the decarboxylation of L-glutamate to GABA. The GABA antiporter (GadC) exports the GABA into the extracellular medium and brings the glutamate into the cells [4] . Owing to its industrial importance, various glutamate decarboxylases have been studied to enhance GABA production. The Lactobacillus brevis glutamate decarboxylase was overexpressed in Bacillus subtilis to produce 0.4 g/l of GABA from 30 g/l of monosodium glutamate (MSG) [5] . By overexpression of rice glutamate decarboxylase in Bifidobacterium longum, 0.1 g/l of GABA was obtained from 30 g/l of MSG [6] . When the glutamate decarboxylase and GABA antiporter were co-overexpressed in the E. coli strain, the GABA obtained was 5.46 g/l from 10 g/l of MSG [7] .
The synthetic scaffold complex is a novel tool to engineer the efficiency of metabolic pathways. The scaffold complex can closely co-localize pathway enzymes using proteinprotein interaction domains and ligands. Since the pathway enzymes are closely co-localized, the reactant from the pathways has a higher chance of being converted into the targeted metabolic product. Likewise, the metabolic flux through the pathway enzymes will increase, due to the formation of a scaffold complex. The introduction of the synthetic scaffold complex on D-glucaric acid production results in a 5-fold increase over the non-scaffold control [8] .
Neurospora crassa is an ascomycete, a red bread mold. Glutamate decarboxylase from N. crassa is a monomeric protein and is considered to be useful for industrial application because of its ease of purification [9] . The genome of N. crassa has been completely sequenced and reported [10] . In our previous study, the expression of N. crassa GadB in E. coli yielded a final GABA concentration of 5.26 g/l from 10 g/l of MSG [11] . In this study, N. crassa GadB and E. coli GadC were co-localized in E. coli via three different synthetic scaffold strategies to improve GABA production. The culture conditions, such as temperature, pH, and glutamate concentration, were optimized.
Materials and Methods

Bacterial Strains, Plasmids, and Medium
The bacterial strains and plasmids used in this study are listed in Table 1 . E. coli XL1-Blue (XB) was used as the host strain. pGEMT vector (Promega, USA) was used for DNA cloning and pMAL-p4X (New England Biolabs, USA) was used to construct the expression plasmids. Chemically competent cells were prepared using a standard procedure and were stored at -80°C until needed. E. coli strains were cultured at 37°C and 250 rpm in Luria-Bertani (LB) broth (10 g/l bacto-tryptone, 5 g/l bacto-yeast extract, and 5 g/l NaCl) supplemented with 100 μg/ml ampicillin sodium salt for the selection of transformants harboring recombinant plasmids [12] .
Cloning of gad Genes
The N. crassa gadB and E. coli gadC genes were amplified using the Expand high-fidelity polymerase chain reaction (PCR) system (Roche Molecular Biochemicals, Germany) from the genomic DNA of N. crassa and E. coli, respectively. The SH3 domain and SH3 ligand genes were PCR amplified from the pJD758 plasmid, which was kindly provided by Professor John E Dueber [8, 13] . Then, the SH3 domain gene was fused to the C-terminus of gadB by overlap PCR to make gadB-SH3D. The SH3 ligand was attached to the N-terminus, C-terminus, and 233 r d amino acid residue of the E. coli gadC gene to make gadCN-SH3L, gadCC-SH3L, and gadCS-SH3L, respectively. The PCR primers used in this study are listed in Table 2 . The PCR products were purified using a GENEALL PCR purification kit (General Biosystem, Korea) and cloned into the pGEMT vector. The N. crassa gadB-SH3D genes were cloned into pMAL-p4X using NdeI and BamHI restriction sites to construct the pHBN plasmids. The E. coli gadCN-SH3L gene was cloned downstream of the gadB-SH3D genes using BamHI and XbaI restriction sites to construct pH1BN expression plasmids. The E. coli gadCS-SH3L gene was cloned into pHBD using BamHI and XbaI restriction sites to construct the pH2BN expression plasmids. The E. coli gadCC-SH3L gene was cloned into pHBD using BamHI and XbaI restriction sites to construct pH3BN expression plasmids.
Expression of gadB and gadC Genes
Recombinant E. coli strains (XB) containing heterologous plasmids were cultivated in a 250 ml flask in 100 ml of LB at 37ºC and 250 rpm. When the OD 6 0 0 reached 1.2, gene expression was Table 1 . List of bacterial strains and plasmids used in this study. induced with 0.5 mM IPTG for 18 h at 30ºC. Then, the cells were pelleted and broken open by sonication (30 sec, 1 min pause, repeated 3 times). The supernatant fraction was obtained by centrifugation at 12,000 ×g for 30 min at 4ºC and it was used for SDS-PAGE analysis.
GABA Bioconversion and Analysis
Recombinant E. coli XB strains harboring pHBN, pH1BN, pH2BN and pH3BN plasmids and recombinant E. coli XBT strain harboring pH1BP were cultivated in 250 ml flasks with 100 ml of LB (100 μg/ml ampicillin) containing 10 g/l MSG at 37°C and 250 rpm. When the OD 6 0 0 reached 1.2, gene expression was induced with 0.5 mM IPTG. Then, the pH was adjusted to 3.5 and the strain was incubated at 30°C and 250 rpm for 48 h.
The GABA bioconversions were quantitatively analyzed by HPLC using an OptimaPak C18 column (4.6 × 150 mm) (RS Tech Corporation, Korea). The sample preparation was performed as follows. Samples (1 ml) were taken from the culture at every 12 h to analyze the GABA production and samples were centrifuged at 12,000 rpm for 5 min. Then, 100 μl of the supernatant was added to an Eppendorf tube. Next, 200 μl of a 1 M sodium bicarbonate buffer at a pH of 9.8, 100 μl of 80 g/l dansyl chloride in acetonitrile, and 600 μl of double-distilled water were added to make a 1 ml reaction mixture. The mixture was then incubated at 80°C for 40 min. Subsequently, 100 μl of 20 μl/ml acetic acid was added to stop the reaction. The mixture was then centrifuged at 12,000 rpm for 5 min. Next, the supernatant was filtered through a 0.22 μm Millipore filter and analyzed by HPLC on an Agilent system using UV detection. Separation of the derivatized samples was performed using a binary non-linear gradient with eluant A (tetrahydrofuran/methanol/50 mM sodium acetate with a pH of 6.2 (5:75:420, by volume)) and eluant B (methanol). The column temperature was set at 30°C and the elution conditions were as follows: equilibration (6 min, 20% B), gradient (20 min, 20-80% B), and cleaning (3 min, 100% B). The flow rate of the mobile phase was 1 ml/min and the samples were detected at a wavelength of 286 nm in the UV region [15] . The standard curve for GABA was generated from 10 standard solutions (1, 2, 3, 4, 5, 6, 7, 8, 9 , and 10 g/l GABA) (Sigma, USA) using the same procedure.
Results
Optimization of GABA Production Conditions
Recombinant E. coli strains containing N. crassa GadB and E. coli GadC were cultured at various temperatures and pH values for the optimization of effective GABA production conditions. Initially, the recombinant strain was cultured at different temperatures of 25°C, 30°C, and 37°C. At 30°C, the highest GABA concentration of 4.97 g/l was obtained from 10 g/l of MSG. At a temperature of 25°C, 3.33 g/l of GABA was obtained, and 37°C produced 4.74 g/l of GABA (Fig. 1A) . Similarly, the recombinant E. coli strain was cultured at 30°C in various pH conditions such as pH 2, 3, 4, and 5. Various concentrations of GABA were obtained from the recombinant strains at different pH conditions. Among the different pH conditions, pH 3 produced the highest GABA concentration, where 4.81 g/l was obtained from 10 g/l of MSG. Hence, pH 3 with a temperature of 30°C was considered to be the optimum condition for higher production of GABA (Fig. 1B) . The recombinant E. coli cells were cultured without the supplementation of MSG and only a negligible amount of GABA was detected.
Construction of Synthetic Scaffold Complex
Generally, for the effective conversion of MSG to GABA, MSG needs to be imported into the E. coli cytosol by the GABA/glutamate antiporter (GadC) and converted to GABA by glutamate decarboxylase (GadB), which is widely distributed in the cytosol. The converted GABA is then secreted via GadC. To make this pathway more efficient, N. crassa GadB was physically connected with E. coli GadC. Through this method, GABA can be produced more efficiently from the E. coli owing to the close co-localization of GadB and GadC enzymes using a scaffold complex (Fig. 2) . The synthetic scaffold complex was introduced between the glutamate decarboxylase and GABA transporter to increase the total GABA production. In the synthetic scaffold complex, the protein-protein interaction SH3 domain was attached to the C-terminus of N. crassa glutamate decarboxylase (GadB) via a glycine-serine linker [2] . The SH3 ligand was attached to the N-terminus, middle, and C-terminus of E. coli GadC via a glycine-serine linker. The constructed recombinant scaffold plasmid was overexpressed by the addition of IPTG in the control of the tac promoter for 8 h of culture and then analyzed by SDS-PAGE (Fig. 3 ).
GABA Production with Scaffold Complex
It was previously reported that protein-protein interaction between the domain and ligand can increase the total carbon influx towards the target pathway, resulting in the improvement of targeted metabolites production [14] . In this study, the employment of a scaffold complex on GadB and GadC induced close co-localization of the enzymes.
The recombinant E. coli strain containing the synthetic scaffold complex was cultured to increase the production of GABA. Initially, the overexpression of recombinant cells without the scaffold complex (pHBN) resulted in the production of 4.9 g/l of GABA from 10 g/l of MSG. The N-terminus scaffold model of GadC with GadB (pH1BN) produced 2.2 g/l GABA after the first 12 h of culture time.
After 48 h of culture time, the amount increased to 5.4 g/l GABA from 10 g/l MSG. Similarly, with the introduction of the sandwich model GadC to GadB scaffold (pH2BN), 4.2 g/l of GABA was produced from 10 g/l MSG. The maximum GABA concentration of 5.8 g/l was obtained with the introduction of the C-terminus synthetic complex to GadC and GadB (pH3BN) (Fig. 4A) . The effect of the synthetic scaffold complex on the production of GABA was studied by analyzing the time profile of GABA production. Based on GABA profiling, the synthetic complex of GadB and GadC provided higher GABA concentration than the strain obtained without the synthetic scaffold complex. This suggests that the scaffold complex between GadB and GadC helped to improve the GABA production from E. coli. During the first 12 h of culture, the pH1BN plasmid complex produced 2.2 g/l GABA, whereas the pHBN plasmid produced only 1.1 g/l GABA from 10 g/l MSG. The synthetic scaffold complex provided higher GABA conversion in a shorter period with higher GABA yield. Overall, among the plasmids, the pH3BN C-terminus synthetic scaffold complex produced the highest GABA concentration of 5.8 g/l from 48 h of culture with a GABA yield of 96.6%.
GABA Production by Pathway-Engineered Strain
The produced GABA from the E. coli has a chance of being redirected into the TCA cycle by the enzyme GABA aminotransferase (GabT). The effect of the GabT enzyme on GABA production was evaluated by the mutant E. coli strain (XBT) harboring pH3BN plasmid, in which the GabT gene was knocked out. The time profile of GABA production from the pH3BN plasmid was analyzed between the XB and XBT strains. The results indicated that the E. coli XBT strain containing the pH3BN plasmid produced the highest GABA concentration of 5.94 g/l from 10 g/l of MSG (Fig. 4B) . The synthesized GABA was prevented from being redirected back into the TCA cycle by the mutation in E. coli. Hence, the recombinant E. coli XBT strain produced 97.5% of GABA yield.
Discussion
The GABA pathway consists of the enzyme glutamate decarboxylase, which can direct the carbon flux of glutamate from the TCA cycle into GABA synthesis. In this study, the N. crassa glutamate decarboxylase and E. coli GABA transporter were co-localized via a synthetic scaffold complex for efficient synthesis of GABA in E. coli. Thus, the formation of the scaffold complex between heterologous GadB and GadC increased the synthesis and secretion of GABA in E. coli.
The efficiency of GABA synthesis is mainly dependent on the activity of GadB enzyme. GadB plays an important role in the production of GABA by converting glutamate into GABA. Since GadB plays a major role in the production of GABA, the employment of effective GadB is necessary to accelerate efficient GABA production. When compared with native E. coli GadB, which has a hexameric structure, N. crassa GadB has a monomeric structure and can be considered to be better for the formation of a scaffold complex and to increase GABA production. In our previous study, we reported that 5.26 g/l of GABA was produced by the overexpression of GadB from N. crassa in E. coli [11] . In this study, N. crassa GadB and E. coli GadC were cooverexpressed with a synthetic scaffold complex in E. coli to improve GABA production. During the production of GABA, the pH and temperature play essential roles in the E. coli. In a previous paper, N. crassa GadB was reported to have higher activity in acidic pH 3, and the E. coli GadC was reported to have higher activity at acidic pH [15, 16] . Similarly, the temperature of 30°C was reported as the optimum condition for GABA production. Considering the previous optimum conditions, the recombinant E. coli strain from this study was tested at various ranges of pH and temperature. It was found that pH 3 is optimum for GABA production in the N. crassa GadB-overexpressed strain, whereas the optimum pH of 3.5 was obtained with the E. coli GadB-overexpressed strain.
The E. coli GadC acts as an antiporter in which the glutamate can effectively be transported inside and GABA can be transported outside of E. coli [16] . Once the glutamate is transported inside the cells, the N. crassa GadB presented in the cytosol of E. coli can effectively convert the glutamate into GABA. Since the GadC is physically attached to GadB, the converted GABA has more opportunities to react with the enzyme GadC and GABA is transported outside the cells. The formation of a scaffold complex between GadB and GadC increases the flux towards GABA production.
GABA production was increased significantly by 2.9-fold during the initial culture period. The pH3BN plasmid elevated the production of GABA to 3.9 g/l within 24 h of culture. In contrast, the pHBN plasmid without a scaffold system produced 1.3 g/l GABA from 24 h of culture. These results clearly showed that the employment of a scaffold complex closely co-localized the GadB and GadC, which leads to more efficient GABA production within a shorter period of time. Productivity as well as product yield is one of the key factors of process efficiency, and as shown in this study, the introduction of a protein scaffold can be considered a very promising strategy for productivity improvement.
Considering the industrial importance of GABA, the employment of heterologous GadB is one of the key factors to realize efficient GABA production. This study shows that the scaffold complex of GadB from N. crassa and GadC from E. coli can improve the efficiency and productivity of GABA in E. coli. Similarly, it demonstrates the practical benefit of a scaffold complex in the improvement of targeted metabolic products.
